ASP8062: Clinical Trials

3 trials of ASP8062, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow ASP8062: new trials by email Literature Review of ASP8062 trials Research Report on ASP8062

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
ASP8062, Placebo ASP8062, buprenorphine/naloxone - Opioid Use Disorder
Phase 1CompletedAstellas Pharma Global Development, Inc.232020-06-292024-11-21
A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects
ASP8062, Alcohol, ASP8062 Placebo - Healthy Volunteers
Phase 1CompletedAstellas Pharma Global Development, Inc.202019-07-162024-11-05
Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects
ASP8062, Placebo - Healthy Volunteers
Phase 1CompletedAstellas Pharma Inc362017-06-202024-10-21

Conditions studied

Opioid-Related Disorders (1)

Sponsors

Astellas Pharma Global Development, Inc. (2)  ·  Astellas Pharma Inc (1)

Countries

United States (2)  ·  Japan (1)

Results publications

PMID 36738100

NIH funding

UG3DA051392 (1)